Aggressive Natural Killer Cell Leukemia Secondary to Hodgkin Lymphoma: a Case Report and Review of the Literature
Meiyi Xu, Danmei Xu(Tongji Hospital), Jianfeng Zhou(Tongji Hospital), Ying Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Meng Li(Bristol-Myers Squibb (United States)), Chunrui Li(Tongji Hospital), Xin Fu
Cited by 2
Related Papers
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
|The Lancet Haematology|2019|248
Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells
|Autophagy|2015|143
Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human
|European Journal of Pharmaceutical Sciences|2008|111